[2]Loibl S, Gianni L. HER2-positive breast cancer. Lancet. 2017 Jun 17;389(10087):2415-2429.[3]Chen H, Gui X, Zhou Z, et al. Distinct ER and PR expression patterns significantly affect the clinical outcomes of early HER2-positive breast cancer: A real-world analysis of 871 patients ...
AR-positive breast cancer, significant gaps remain in understanding AR’s precise functions and therapeutic potential. The systemic management of breast cancer is guided primarily by theranostic biomarkers; ER, PR, HER2, and Ki67 which also dictate the breast cancer classification. The ubiquitous expres...
In this report, we present the case of a female patient with relapsed and metastatic breast cancer, whose histology transformed from initially triplenegative to Luminal-B type (HER2 positive) (i.e., ER, PR, and HER2 positive). She underwent systematic chemotherapy, ...
1. Tarantino P,Hamilton E, Tolaney S M, et al. HER2-Low Breast Cancer: Pathological andClinical Landscape[J]. Journal of Clinical Oncology, 2020, 38(17): 1951-1962. 2. Clinical and molecular characteristics of HER2-low-p...
);while the difference in its expression level wasn't statistically significant between PR(+)and PR(-)cancer tissue(P0.05).Conclusion BRMS1 low expression may play a crucial role in the progression of breast cancer and lymph node metastasis,and BRMS1 expression level is asoociated with ER....
Core biopsy: grade II invasive ductal carcinoma (IDC), estrogen receptor positive (ER+)/progesterone receptor positive (PR+), HER2 immunohistochemistry (IHC) score of 0, Ki-67 33% Lumpectomy and sentinel lymph node (SLN) biopsy: 3.0 cm, grade 2 IDC, 2 SLN negative for malignant cells 21...
【Abstract】Backgroundandpurpose:ProgesteronereceptorfPR)statusprovidespredictivevalueforadjuvantendo— crinetherapyinestrogenreceptorfER)一positivebreastcancerpatients.Itisrecommendedf0rthepatientswithbothER andPRpositivetoreceiveadjuvanthormonetherapy.However,itstillisacontroversialissuehownluchefficacv0fadju— ...
node metastasis (P <0.01).The positive rate of HER2/Neu was significantly higher than that of patients without internal microcalcification,blood flow imaging grade 0~1,and lymph node metastasis (P <0.05).Conclusion The expression of GCDFP-15,ER,PR,C-erbB-2and HER2/Neu in breast cancer ...
While ER+/HER2- breast cancer generally has a more favorable prognosis compared to HER2-positive and triple-negative breast cancer, there remains considerable prognostic variability among patients. Therefore, it is essential to enhance the current prognostic evaluation tools for patients with ER+/HER2-...
[translate] aMinor Out Diameter 未成年人直径 [translate] aEvaluation of ER, PR and HER-2 receptor expression in breast cancer patients presenting to a semi urban cancer centre in Western India. ER、PR和HER-2感受器官表示的评估在当前对一个半都市癌症中心的乳腺癌患者在西印度。 [translate] ...